HEADER ANTIBIOTIC 22-DEC-00 1HHF TITLE DECAPLANIN SECOND P6122-FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: DECAPLANIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: M86-1410 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: UNCULTURED ACTINOMYCETE; SOURCE 3 ORGANISM_TAXID: 100235; SOURCE 4 STRAIN: DSM 4763; SOURCE 5 OTHER_DETAILS: CULTURE HIL Y-86, 36910 KEYWDS ANTIBIOTIC, GLYCOPEPTIDE EXPDTA X-RAY DIFFRACTION AUTHOR C.LEHMANN,L.VERTESSY,G.M.SHELDRICK,Z.DAUTER,M.DAUTER REVDAT 10 29-JUL-20 1HHF 1 COMPND REMARK HETNAM LINK REVDAT 10 2 1 SITE ATOM REVDAT 9 24-JUL-19 1HHF 1 REMARK REVDAT 8 10-JUL-19 1HHF 1 REMARK REVDAT 7 24-APR-19 1HHF 1 REMARK SEQRES LINK REVDAT 6 01-MAY-13 1HHF 1 HETSYN REVDAT 5 11-JUL-12 1HHF 1 REMARK HET HETNAM SITE REVDAT 5 2 1 HETATM ANISOU CONECT MASTER REVDAT 4 13-JUL-11 1HHF 1 VERSN REVDAT 3 24-FEB-09 1HHF 1 VERSN REVDAT 2 09-AUG-05 1HHF 1 REMARK REVDAT 1 11-JUL-05 1HHF 0 JRNL AUTH C.LEHMANN,J.E.DEBRECZENI,G.BUNKOCZI,M.DAUTER,Z.DAUTER, JRNL AUTH 2 L.VERTESY,G.M.SHELDRICK JRNL TITL STRUCTURES OF FOUR CRYSTAL FORMS OF DECAPLANIN JRNL REF HELV.CHIM.ACTA V. 86 1478 2003 JRNL REFN ISSN 0018-019X JRNL DOI 10.1002/HLCA.200390131 REMARK 2 REMARK 2 RESOLUTION. 1.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.179 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.180 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1244 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 24558 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.173 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.174 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1134 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 21989 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 316 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 138 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 541.50 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 348.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 4895 REMARK 3 NUMBER OF RESTRAINTS : 7785 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 ANGLE DISTANCES (A) : 0.027 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.017 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.063 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.095 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.053 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.027 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.089 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1HHF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-DEC-00. REMARK 100 THE DEPOSITION ID IS D_1290005729. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-98 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.83450 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24558 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.470 REMARK 200 RESOLUTION RANGE LOW (A) : 48.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 12.00 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.7400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 11.00 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.960 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: SHELXD, SHARP, DM REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: SAS OF CHLORINE AT 1.5A REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS/HCL, PH=8.5, 2M NH4H2PO4, PH REMARK 280 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.79567 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.59133 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 65.69350 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 109.48917 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 21.89783 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 43.79567 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 87.59133 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 109.48917 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 65.69350 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 21.89783 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4680 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH D2023 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. REMARK 400 HERE, DECAPLANIN IS REPRESENTED BY GROUPING TOGETHER THE REMARK 400 SEQUENCE (SEQRES) AND THE THREE LIGANDS (HET) BGC, ERE AND RAM. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DECAPLANIN REMARK 400 CHAIN: A, B, C, D REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 7 REMARK 400 COMPONENT_2: SUGAR RESIDUES 8, 9 AND 10 REMARK 400 DESCRIPTION: DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. REMARK 400 THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE REMARK 400 CONFIGURATION D-D-L-D-D-L-L, GLYCOSYLATED REMARK 400 BY A MONOSACCHARIDE AND A DISACCHARIDE REMARK 400 REMARK 400 THE DECAPLANIN IS GLYCOPEPTIDE, A MEMBER OF ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: DECAPLANIN REMARK 400 CHAIN: A, B, C, D, E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 COMPONENT_2: RESIDUE BGC REMARK 400 COMPONENT_3: RESIDUE ERE REMARK 400 COMPONENT_4: RESIDUE RAM REMARK 400 DESCRIPTION: DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD REMARK 400 IS A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L- REMARK 400 L, GLYCOSYLATED REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 3 -52.14 -120.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HHA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P6122 REMARK 900 RELATED ID: 1HHC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P21, SECOND FORM REMARK 900 RELATED ID: 1HHF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DECAPLANIN - SPACE GROUP P6122, SECOND FORM DBREF 1HHF A 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HHF B 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HHF C 1 7 NOR NOR00692 NOR00692 1 7 DBREF 1HHF D 1 7 NOR NOR00692 NOR00692 1 7 SEQRES 1 A 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 B 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 C 7 MLU OMZ ASN GHP GHP OMX 3FG SEQRES 1 D 7 MLU OMZ ASN GHP GHP OMX 3FG MODRES 1HHF OMX A 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HHF OMX B 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HHF OMX C 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE MODRES 1HHF OMX D 6 TYR (BETAR)-BETA-HYDROXY-L-TYROSINE HET MLU A 1 9 HET OMZ A 2 14 HET GHP A 4 11 HET GHP A 5 11 HET OMX A 6 13 HET 3FG A 7 13 HET MLU B 1 9 HET OMZ B 2 14 HET GHP B 4 11 HET GHP B 5 11 HET OMX B 6 13 HET 3FG B 7 13 HET MLU C 1 9 HET OMZ C 2 14 HET GHP C 4 11 HET GHP C 5 11 HET OMX C 6 13 HET 3FG C 7 13 HET MLU D 1 9 HET OMZ D 2 14 HET GHP D 4 11 HET GHP D 5 11 HET OMX D 6 13 HET 3FG D 7 13 HET BGC E 1 11 HET RAM E 2 10 HET BGC F 1 11 HET RAM F 2 10 HET BGC G 1 11 HET RAM G 2 10 HET BGC H 1 11 HET RAM H 2 10 HET ERE A 8 10 HET CL A1001 1 HET CL A1002 1 HET ERE B 8 10 HET ERE C 8 10 HET CL C1003 1 HET CL C1004 1 HET PO4 C1005 5 HET PO4 C1006 5 HET ERE D 8 10 HETNAM MLU N-METHYL-D-LEUCINE HETNAM OMZ (BETAR)-3-CHLORO-BETA-HYDROXY-D-TYROSINE HETNAM GHP (2R)-AMINO(4-HYDROXYPHENYL)ETHANOIC ACID HETNAM OMX (BETAR)-BETA-HYDROXY-L-TYROSINE HETNAM 3FG (2S)-AMINO(3,5-DIHYDROXYPHENYL)ETHANOIC ACID HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM RAM ALPHA-L-RHAMNOPYRANOSE HETNAM ERE 4-EPI-VANCOSAMINE HETNAM CL CHLORIDE ION HETNAM PO4 PHOSPHATE ION HETSYN ERE 4-EPI-VANCOSAMINE FORMUL 1 MLU 4(C7 H15 N O2) FORMUL 1 OMZ 4(C9 H10 CL N O4) FORMUL 1 GHP 8(C8 H9 N O3) FORMUL 1 OMX 4(C9 H11 N O4) FORMUL 1 3FG 4(C8 H9 N O4) FORMUL 5 BGC 4(C6 H12 O6) FORMUL 5 RAM 4(C6 H12 O5) FORMUL 9 ERE 4(C7 H15 N O3) FORMUL 10 CL 4(CL 1-) FORMUL 16 PO4 2(O4 P 3-) FORMUL 19 HOH *94(H2 O) LINK C MLU A 1 N OMZ A 2 1555 1555 1.33 LINK C OMZ A 2 N ASN A 3 1555 1555 1.35 LINK OH OMZ A 2 C5 GHP A 4 1555 1555 1.39 LINK C ASN A 3 N GHP A 4 1555 1555 1.32 LINK C GHP A 4 N GHP A 5 1555 1555 1.35 LINK C3 GHP A 4 OH OMX A 6 1555 1555 1.39 LINK O4 GHP A 4 C1 BGC E 1 1555 1555 1.42 LINK C GHP A 5 N OMX A 6 1555 1555 1.33 LINK C3 GHP A 5 CG1 3FG A 7 1555 1555 1.49 LINK C OMX A 6 N 3FG A 7 1555 1555 1.36 LINK OC OMX A 6 C1 ERE A 8 1555 1555 1.42 LINK C MLU B 1 N OMZ B 2 1555 1555 1.33 LINK C OMZ B 2 N ASN B 3 1555 1555 1.35 LINK OH OMZ B 2 C5 GHP B 4 1555 1555 1.39 LINK C ASN B 3 N GHP B 4 1555 1555 1.32 LINK C GHP B 4 N GHP B 5 1555 1555 1.35 LINK C3 GHP B 4 OH OMX B 6 1555 1555 1.39 LINK O4 GHP B 4 C1 BGC F 1 1555 1555 1.42 LINK C GHP B 5 N OMX B 6 1555 1555 1.33 LINK C3 GHP B 5 CG1 3FG B 7 1555 1555 1.49 LINK C OMX B 6 N 3FG B 7 1555 1555 1.37 LINK OC OMX B 6 C1 ERE B 8 1555 1555 1.42 LINK C MLU C 1 N OMZ C 2 1555 1555 1.33 LINK C OMZ C 2 N ASN C 3 1555 1555 1.35 LINK OH OMZ C 2 C5 GHP C 4 1555 1555 1.39 LINK C ASN C 3 N GHP C 4 1555 1555 1.32 LINK C GHP C 4 N GHP C 5 1555 1555 1.35 LINK C3 GHP C 4 OH OMX C 6 1555 1555 1.40 LINK O4 GHP C 4 C1 BGC G 1 1555 1555 1.40 LINK C GHP C 5 N OMX C 6 1555 1555 1.33 LINK C3 GHP C 5 CG1 3FG C 7 1555 1555 1.49 LINK C OMX C 6 N 3FG C 7 1555 1555 1.36 LINK OC OMX C 6 C1 ERE C 8 1555 1555 1.40 LINK C MLU D 1 N OMZ D 2 1555 1555 1.32 LINK C OMZ D 2 N ASN D 3 1555 1555 1.34 LINK OH OMZ D 2 C5 GHP D 4 1555 1555 1.39 LINK C ASN D 3 N GHP D 4 1555 1555 1.33 LINK C GHP D 4 N GHP D 5 1555 1555 1.36 LINK C3 GHP D 4 OH OMX D 6 1555 1555 1.39 LINK O4 GHP D 4 C1 BGC H 1 1555 1555 1.41 LINK C GHP D 5 N OMX D 6 1555 1555 1.33 LINK C3 GHP D 5 CG1 3FG D 7 1555 1555 1.48 LINK C OMX D 6 N 3FG D 7 1555 1555 1.36 LINK OC OMX D 6 C1 ERE D 8 1555 1555 1.41 LINK O2 BGC E 1 C1 RAM E 2 1555 1555 1.43 LINK O2 BGC F 1 C1 RAM F 2 1555 1555 1.43 LINK O2 BGC G 1 C1 RAM G 2 1555 1555 1.43 LINK O2 BGC H 1 C1 RAM H 2 1555 1555 1.43 CISPEP 1 GHP A 5 OMX A 6 0 6.38 CISPEP 2 GHP B 5 OMX B 6 0 5.00 CISPEP 3 GHP C 5 OMX C 6 0 4.37 CISPEP 4 GHP D 5 OMX D 6 0 10.32 CRYST1 60.101 60.101 131.387 90.00 90.00 120.00 P 61 2 2 48 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016639 0.009606 0.000000 0.00000 SCALE2 0.000000 0.019213 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007611 0.00000 MTRIX1 1 -0.101480 -0.989450 0.103360 65.61858 1 MTRIX2 1 -0.993860 0.096220 -0.054690 62.96038 1 MTRIX3 1 0.044170 -0.108270 -0.993140 48.16151 1 MTRIX1 2 -0.101480 -0.989450 0.103360 65.61858 1 MTRIX2 2 -0.993860 0.096220 -0.054690 62.96038 1 MTRIX3 2 0.044170 -0.108270 -0.993140 48.16151 1 MTRIX1 3 0.839660 0.542960 -0.012650 8.49048 1 MTRIX2 3 -0.538600 0.835470 0.109070 30.28199 1 MTRIX3 3 0.069790 -0.084770 0.993950 -12.53756 1 HETATM 1 N MLU A 1 43.876 19.730 26.459 1.00 22.87 N ANISOU 1 N MLU A 1 2777 3035 2878 -613 788 -13 N HETATM 2 CN MLU A 1 44.944 18.775 26.842 1.00 26.20 C ANISOU 2 CN MLU A 1 2490 3408 4057 -336 1399 304 C HETATM 3 CA MLU A 1 43.449 20.787 27.423 1.00 21.03 C ANISOU 3 CA MLU A 1 2398 2935 2658 -613 670 126 C HETATM 4 C MLU A 1 44.611 21.526 28.030 1.00 21.12 C ANISOU 4 C MLU A 1 2734 3008 2283 -844 684 323 C HETATM 5 O MLU A 1 44.890 21.402 29.227 1.00 22.37 O ANISOU 5 O MLU A 1 3107 3054 2339 -753 495 359 O HETATM 6 CB MLU A 1 42.481 21.731 26.749 1.00 21.84 C ANISOU 6 CB MLU A 1 2797 2751 2751 -698 517 275 C HETATM 7 CG MLU A 1 41.093 21.182 26.415 1.00 21.88 C ANISOU 7 CG MLU A 1 2584 2877 2852 -435 520 463 C HETATM 8 CD1 MLU A 1 40.315 22.223 25.626 1.00 26.58 C ANISOU 8 CD1 MLU A 1 3289 3171 3637 -698 5 1157 C HETATM 9 CD2 MLU A 1 40.365 20.685 27.604 1.00 22.61 C ANISOU 9 CD2 MLU A 1 2805 2797 2991 -608 545 624 C HETATM 10 N OMZ A 2 45.321 22.308 27.223 1.00 20.51 N ANISOU 10 N OMZ A 2 2790 2615 2389 -786 578 325 N HETATM 11 CA OMZ A 2 46.476 23.052 27.718 1.00 20.53 C ANISOU 11 CA OMZ A 2 2898 2774 2130 -880 550 239 C HETATM 12 C OMZ A 2 47.746 22.909 26.895 1.00 20.18 C ANISOU 12 C OMZ A 2 2841 2659 2165 -940 502 290 C HETATM 13 O OMZ A 2 48.784 23.446 27.353 1.00 21.49 O ANISOU 13 O OMZ A 2 2750 2999 2418 -822 244 253 O HETATM 14 CB OMZ A 2 46.153 24.575 27.901 1.00 21.16 C ANISOU 14 CB OMZ A 2 2905 2742 2392 -896 601 250 C HETATM 15 OC OMZ A 2 45.027 24.658 28.768 1.00 22.46 O ANISOU 15 OC OMZ A 2 3150 2988 2395 -919 688 -27 O HETATM 16 CG OMZ A 2 45.844 25.210 26.576 1.00 20.30 C ANISOU 16 CG OMZ A 2 2817 2579 2318 -794 582 78 C HETATM 17 CD1 OMZ A 2 46.850 25.911 25.952 1.00 19.81 C ANISOU 17 CD1 OMZ A 2 2658 2318 2553 -566 657 154 C HETATM 18 CD2 OMZ A 2 44.619 25.038 25.934 1.00 20.25 C ANISOU 18 CD2 OMZ A 2 2682 2709 2303 -708 714 -63 C HETATM 19 CE1 OMZ A 2 46.615 26.462 24.733 1.00 20.28 C ANISOU 19 CE1 OMZ A 2 2683 2605 2417 -736 889 141 C HETATM 20 CL OMZ A 2 47.968 27.158 23.893 1.00 35.97 CL ANISOU 20 CL OMZ A 2 4786 4175 4706 -902 982 252 CL HETATM 21 CE2 OMZ A 2 44.410 25.580 24.685 1.00 19.90 C ANISOU 21 CE2 OMZ A 2 2731 2552 2278 -637 659 -90 C HETATM 22 CZ OMZ A 2 45.447 26.231 24.038 1.00 19.77 C ANISOU 22 CZ OMZ A 2 2791 2422 2298 -453 786 -66 C HETATM 23 OH OMZ A 2 45.245 26.663 22.727 1.00 20.17 O ANISOU 23 OH OMZ A 2 2881 2445 2339 -304 865 -27 O